Regenxbio (RGNX) Amortizatization of Intangibles (2015 - 2025)
Regenxbio (RGNX) recorded quarterly Amortizatization of Intangibles of $1.2 million in Q4 2025, down 32.58% quarter-over-quarter from $1.8 million in Q3 2025, and up 10.03% on a YoY basis from $1.1 million in Q4 2024.
Regenxbio (RGNX) Amortizatization of Intangibles (2015 - 2025) Analysis & Trends
Regenxbio's Amortizatization of Intangibles history runs 11 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- In Q4 2025, Amortizatization of Intangibles rose 10.03% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $5.5 million (up 32.22% YoY), while the FY2025 annual figure was $5.5 million, up 32.22% from the prior year.
- Amortizatization of Intangibles was $1.2 million for Q4 2025 at Regenxbio, down from $1.8 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.8 million in Q3 2025 to a low of -$1.6 million in Q2 2021.
- Historically, Amortizatization of Intangibles has averaged -$80900.0 across 5 years, with a median of -$123500.0 in 2023.
- The sharpest annual moves came in 2021 and 2024: Amortizatization of Intangibles slumped 3202.56% in 2021, then jumped 889.47% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$1.5 million in 2021, then soared by 38.36% to -$903000.0 in 2022, then jumped by 126.8% to $242000.0 in 2023, then surged by 361.57% to $1.1 million in 2024, then climbed by 10.03% to $1.2 million in 2025.
- The last three Amortizatization of Intangibles figures came in at $1.2 million (Q4 2025), $1.8 million (Q3 2025), and $1.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Regenxbio | 315.63 Mn | 85.56 Mn | - | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.23 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | 468,000.00 |
| Mar 31, 2024 | 468,000.00 |
| Dec 31, 2023 | 242,000.00 |
| Dec 31, 2023 | 242,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Sep 30, 2023 | 133,000.00 |